CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

HSBC Adjusts Price Target on Regeneron Pharmaceuticals to $800 From $990

Negative
AI Analysis

Summary

HSBC reduced its price target on Regeneron Pharmaceuticals from $990 to $800, representing a significant downward revision of the analyst's valuation estimate.

Importance:2/10
Sentiment:
-0.70
price_target_reductionanalyst_rating
Related Companies

Read the original article

Published by yahoo_finance on July 6, 2026 11:23 AM

Read Original